High-tech printing may help eliminate painful shots

This microneedle array has backward-facing barbs that interlock with tissue when inserted, enhancing adhesion. Credit: Riddish Morde

Painful hypodermic needles may not be needed in the future to give shots, inject drugs and get blood samples.

With 4D printing, Rutgers engineers have created tiny needles that mimic parasites that attach to tissues and could replace hypodermic needles, according to a study in the journal Advanced Functional Materials.

While 3D printing builds objects layer by layer, 4D goes further with smart materials that are programmed to change shape after printing. Time is the fourth dimension that allows materials to morph into new shapes.

“We think our 4D-printed microneedle array will allow for more robust and sustained use of minimally invasive, pain-free and easy-to-use microneedles for delivering drugs, healing wounds, biosensing and other soft tissue applications,” said senior author Howon Lee, an assistant professor in the Department of Mechanical and Aerospace Engineering in the School of Engineering at Rutgers University-New Brunswick.

This YouTube video by Riddish Morde shows microneedles applied to chicken muscle tissue.

Hypodermic needles are widely used in hospitals and labs to extract blood and inject drugs, causing pain, scarring skin and posing an infection risk. People with diabetes often take blood samples multiple times a day with needles to monitor blood sugar levels.

Microneedles (miniaturized needles) are gaining attention because they are short, thin and minimally invasive, reduce pain and the risk of infection and are easy-to-use. But their weak adhesion to tissues is a major challenge for controlled drug delivery over the long run or for biosensing, which involves using a device to detect DNA, enzymes, antibodies and other health indicators.

In nature, some insects and other organisms have developed microscopic features that adhere to tissue, such as the microhooks of parasites, barbed stingers of honeybees and scaled quills of porcupines. Inspired by these examples, Rutgers engineers developed a microneedle that interlocks with tissue when inserted, enhancing adhesion. They combined a micro 3D-printing technique and a 4D-printing approach to create backward-facing barbs on a microneedle.

Using chicken muscle tissue as a model, the researchers showed that tissue adhesion with their microneedle is 18 times stronger than with a barbless microneedle. Their creation outperforms previously reported examples, resulting in more stable and robust drug delivery, collection of bio-fluids and biosensing, the study says.

###

The study's three co-lead authors include Daehoon Han, a former Rutgers doctoral student who is now a postdoc at the University of Minnesota, Riddish S. Morde, a former Rutgers master's student, and a researcher at the University of Pisa in Italy. Rutgers doctoral student Chen Yang and researchers at the University of Pisa contributed to the study, which was funded by the New Jersey Health Foundation and Italian Ministry of Education, University and Research.

Media Contact

Todd Bates
todd.bates@rutgers.edu
848-932-0550

 @RutgersU

http://www.rutgers.edu 

All latest news from the category: Medical Engineering

The development of medical equipment, products and technical procedures is characterized by high research and development costs in a variety of fields related to the study of human medicine.

innovations-report provides informative and stimulating reports and articles on topics ranging from imaging processes, cell and tissue techniques, optical techniques, implants, orthopedic aids, clinical and medical office equipment, dialysis systems and x-ray/radiation monitoring devices to endoscopy, ultrasound, surgical techniques, and dental materials.

Back to home

Comments (0)

Write a comment

Newest articles

Prostate cancer organoids open path to precision oncology

A multi-institutional team of investigators led by bioengineer Ankur Singh has developed research tools that shed new light on a virtually untreatable form of prostate cancer, opening a pathway that may lead…

Experimental compound counters diabetic complications

An experimental compound reduced complications of type 1 and type 2 diabetes in mice – not by lowering blood sugar – but by countering its consequences: cell death, inflammation, and…

Taking new aim at COVID-19

The coronavirus’s tangled strands of RNA could offer new ways to treat people who get infected. To the untrained eye, the loops, kinks and folds in the single strand of…

Partners & Sponsors